Tags

Type your tag names separated by a space and hit enter

Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus.
Emerg Infect Dis. 2016 10; 22(10):1824-6.EI

Abstract

To determine how long antibodies against Middle East respiratory syndrome coronavirus persist, we measured long-term antibody responses among persons serologically positive or indeterminate after a 2012 outbreak in Jordan. Antibodies, including neutralizing antibodies, were detectable in 6 (86%) of 7 persons for at least 34 months after the outbreak.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

27332149

Citation

Payne, Daniel C., et al. "Persistence of Antibodies Against Middle East Respiratory Syndrome Coronavirus." Emerging Infectious Diseases, vol. 22, no. 10, 2016, pp. 1824-6.
Payne DC, Iblan I, Rha B, et al. Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2016;22(10):1824-6.
Payne, D. C., Iblan, I., Rha, B., Alqasrawi, S., Haddadin, A., Al Nsour, M., Alsanouri, T., Ali, S. S., Harcourt, J., Miao, C., Tamin, A., Gerber, S. I., Haynes, L. M., & Al Abdallat, M. M. (2016). Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus. Emerging Infectious Diseases, 22(10), 1824-6. https://doi.org/10.3201/eid2210.160706
Payne DC, et al. Persistence of Antibodies Against Middle East Respiratory Syndrome Coronavirus. Emerg Infect Dis. 2016;22(10):1824-6. PubMed PMID: 27332149.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus. AU - Payne,Daniel C, AU - Iblan,Ibrahim, AU - Rha,Brian, AU - Alqasrawi,Sultan, AU - Haddadin,Aktham, AU - Al Nsour,Mohannad, AU - Alsanouri,Tarek, AU - Ali,Sami Sheikh, AU - Harcourt,Jennifer, AU - Miao,Congrong, AU - Tamin,Azaibi, AU - Gerber,Susan I, AU - Haynes,Lia M, AU - Al Abdallat,Mohammad Mousa, Y1 - 2016/10/15/ PY - 2016/6/23/entrez PY - 2016/6/23/pubmed PY - 2018/2/3/medline KW - Jordan KW - MERS-CoV KW - Middle East respiratory syndrome KW - antibody KW - novel coronavirus KW - respiratory infections KW - serology KW - severe acute respiratory illness KW - viruses SP - 1824 EP - 6 JF - Emerging infectious diseases JO - Emerg Infect Dis VL - 22 IS - 10 N2 - To determine how long antibodies against Middle East respiratory syndrome coronavirus persist, we measured long-term antibody responses among persons serologically positive or indeterminate after a 2012 outbreak in Jordan. Antibodies, including neutralizing antibodies, were detectable in 6 (86%) of 7 persons for at least 34 months after the outbreak. SN - 1080-6059 UR - https://www.unboundmedicine.com/medline/citation/27332149/Persistence_of_Antibodies_against_Middle_East_Respiratory_Syndrome_Coronavirus_ L2 - https://doi.org/10.3201/eid2210.160706 DB - PRIME DP - Unbound Medicine ER -